Deciphera Pharmaceuticals, Inc. DCPH
Day range unavailable
52-week range unavailable
DCPH free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-147,475,000 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | -147,475,000 | 6,228,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -153,703,000 | 89,091,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -242,794,000 | 2,198,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -244,992,000 | -90,761,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -154,231,000 | -66,323,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -87,908,000 | -50,800,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -37,108,000 | -13,795,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -23,313,000 | -9,902,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -13,411,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.